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Abstract: Circadian rhythm disturbances have been consistently associated with the development of
several diseases, particularly cardiovascular diseases (CVDs). A central clock in the brain maintains
the daily rhythm in accordance with the external environment. At the molecular level, the clock is
maintained by “clock genes”, the regulation of which is mainly due to DNA methylation, a molecular
mechanism of gene expression regulation, able to react to and be reprogrammed by environmental
exposure such as exposure to particulate matter (PM). In 55 patients with a diagnosis of acute
ischemic stroke, we showed that PM2.5 exposure experienced before the event influenced clock genes
methylation (i.e., circadian locomotor output cycles protein kaput CLOCK, period 2 PER2, cryprochrome
1 CRY1, Neuronal PAS Domain Protein 2 NPAS2), possibly modulating the patient prognosis after the
event, as cryptochrome 1 CRY1 and period 1 PER1 methylation levels were associated with the Rankin
score. Moreover, if PM2.5 annual average was low, CRY1/CRY2 methylation levels were positively
associated with the National Institutes of Health Stroke Scale (NIHSS) score, whereas they were
negatively associated if PM2.5 exposure was high. Whether epigenetic changes in clock genes need
to be considered as a prognostic marker of stroke or rather a causal agent in stroke development
remains to be determined. Further studies are needed to determine the role of clock gene methylation
in regulating the response to and recovery after a stroke event.
Keywords: air pollution; stroke; clock gene methylation; NIHSS; Rankin
1. Introduction
All living organisms display behavioral and biochemical oscillations over a 24 h period.
These circadian rhythms are evolutionarily preserved and are driven by the necessity to synchronize
biological activity with the ever-changing, but predictable environment of the rotating Earth [1].
Circadian clocks cause self-sustaining, cell-autonomous fluctuations across a time period of approximately
24 h (circa diem, approximately one day) [2]. Circadian rhythms are not only stimulus-evoked responses,
since they continue in the absence of external signals and they can adjust to local time [3].
An increasing amount of evidence shows that interference with circadian rhythms might play
a key role in the development of several diseases [4]. In particular, disruption of the timing of
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biological functions that are normally synchronized [5], incorrect timing of food intake [6], and sleep
loss/disturbance [7,8] have been associated with disease onset.
Recently, growing interest has been focused on the role of clock genes in the pathogenesis and
progression of cardiovascular disease (CVD), the leading cause of death in a majority of countries,
representing a substantial public health threat. Two main clocks, a central one and a peripheral
one, regulate all biological functions, including cardiovascular function such as heart rate and blood
pressure [9]. It has been suggested that a loss of synchronization between the central and peripheral
clocks may underlie the onset and progression of CVDs [10,11], while their role in cerebrovascular
diseases and the possible link with an autonomic nervous system derangement in acute stroke is
still unknown.
The molecular basis of circadian rhythms and the complex pathway regulating them involves
a positive (+) and a negative (−) interconnected feedback loop modulating “clock gene” expression.
In the positive loop, the transcriptional–translational feedback loop (TTL), the transcriptional activators
ARNTL (Aryl hydrocarbon receptor nuclear translocator-like protein 1) dimerize with CLOCK, or
possibly with neuronal NPAS2 proteins in brain tissue [12,13], and this heterodimer binds to the
promoter elements (CACGTG) present in clock and clock-controlled genes (CCGs) [12,13]. In the
negative loop, the clock genes Period (PER1, PER2, and PER3) and Cryptochrome (CRY1 and CRY2),
when activated by the CLOCK–ARNTL heterodimer, constitute the negative portion of the TTL: PER1,
PER2, PER3, CRY1, and CRY2 proteins form heterodimers that eventually enter the nucleus to inhibit
transcription by binding to the CLOCK–ARNTL complex [12,13].
The regulation of clock genes is mainly due to DNA methylation [14], one of the mechanisms of
gene expression regulation, which is able to react to and be reprogrammed by environmental stimuli,
such as particulate matter (PM) [15,16].
PM exposure has been associated with all-cause mortality in several studies, and the strongest
associations have been repeatedly reported for CVDs [17–19]. Thus, the health effects of PM on CVDs
are of particular value for health risk assessment. Ischemic heart disease (IHD) and stroke constitute
the major diagnoses contributing to the CVD burden, and contribute to both increased morbidity and
mortality [20].
To the best of our knowledge, only one study has previously reported the effects of PM exposure
on the methylation pattern of genes in the circadian pathway (clock genes), in a cohort of pregnant
women and their newborns [21].
In the present study, we evaluated the effects of PM2.5 exposure experienced before stroke on clock
genes’ methylation levels, in order to investigate their possible role in modulating patients’ prognosis
after the event. We developed a cross-sectional study investigating the effects of clock gene methylation
and particulate air pollution on patients residing in the Lombardy region of Italy and admitted to the
Emergency Department (ED) of the Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico
(Milan, Italy) with a diagnosis of acute ischemic stroke. We enrolled 55 incident acute ischemic stroke
cases, collected within 4.5 h from the onset of neurological symptoms.
2. Results
2.1. Study Population, DNA Methylation Levels, and Exposure Levels
The study population included 55 subjects with BMI 24.8±3.8 kg/m2, aged 74.6 ± 13.9 years; 56.4%
were males and 43.6% females and 67.3% had a previous diagnosis of hypertension (blood pressure:
systolic 162 ± 26 mmHg and diastolic 89 ± 16). Of the group, 70.9% had no previous stroke or transient
ischemic attack (TIA) and 65.5% had never smoked (Table 1).
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Table 1. Demographic and clinical characteristics of the studied population (n = 55).
Characteristics Value
Age (years) 74.6 ± 13.9
Sex:
Male 31 (56.4%)
Female 24 (43.6%)
BMI (kg/m2) 24.8 ± 3.8
Blood pressure (mmHg):
Systolic 162 ± 26
Diastolic 89 ± 16
Glucose (mg/dL) 120.2 ± 30.9
Hypertension:
Yes 37 (67.3%)
Diabetes:
Yes 8 (14.5%)
Atrial fibrillation:
Yes 17 (30.9%)
Heart failure:
Yes 6 (10.9%)
Previous stroke or TIA:
Yes 16 (29.1%)
Smoking status:
Never smoked 36 (65.5%)
Current smoker 12 (21.8%)
n.a. 7 (12.7%)
Hb (g/dL) 13.8 ± 1.7
Ht (%) 40.1 ± 4.3
Plt × 103 (N/µL) 225 (193, 304)
AST (U/L) 23.1 ± 8.8
ALT (U/L) 19.2 ± 9.1
PT 1.12 ± 0.37
aPTT 0.95 ± 0.12
Albumin (g/dL) 3.9 ± 0.4
Creatinine (mg/dL) 1.03 ± 0.34
C-reactive protein (mg/dL) 0.34 (0.15, 0.66)
Total cholesterol (mg/dL) 183 ± 34.9
Plt and C-reactive protein are expressed as median (Q1, Q3) because values were not normally distributed.
Other variables are expressed as mean ± standard deviation. ALT: alanine aminotransferase; AST: aspartate
aminotransferase; BMI: body mass index; PT: prothrombin time; aPTT: activated partial thromboplastin time; TIA:
transient ischemic attack.
Clinical features of subjects’ acute ischemic stroke are reported in Table 2. Mean NIHSS (National
Institutes of Health Stroke Scale) score on admission was 7.5 (5, 14); a total 10.9% of strokes were of
atherothrombotic origin, while 38.2% were cardioembolic in nature. The right hemisphere was affected
in 22 (40.0%) patients, and the left in 23 (41.8%).
Modified Rankin score was between 0–2 in 36.4%, between 3–5 in 18.2%, and 6 in 23.6% of patients.
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Table 2. Clinical features of acute ischemic stroke (n = 55).
Characteristics Value
NIHSS score on admission: 7.5 (5,14)
<14 36 (65.5%)
≥14 14 (25.4%)
n.a. 5 (9.1%)
Therapy:
Yes 31 (56.4%)
n.a. 8 (14.5%)
TOAST:
Atherombotic 6 (10.9%)
Cardioembolic 21 (38.2%)
Lacunar 2 (3.7%)
Indeterminate 16 (29.1%)
n.a. 10 (18.1%)
Hemisphere of stroke:
Right 22 (40.0%)
Left 23 (41.8%)
Bilateral 3 (5.5%)
n.a. 7 (12.7%)
Circle segments:
Anterior 42 (76.4%)
Posterior 6 (10.9%)
n.a. 7 (12.7%)
Modified Rankin score at 3 months: 2.95 ±2.5
0–2 20 (36.4%)
3–5 10 (18.2%)
6 13 (23.6%)
n.a. 12 (21.8%)
NIHSS on admission is expressed as median (Q1, Q3) because values were not normally distributed. Modified Rankin
scale at three months is reported as mean ± standard deviation. NIHSS: National Institutes of Health Stroke Scale;
TOAST: Trial of Org 10172 in Acute Stroke Treatment (classification of stroke subtypes based on etiology as a
main criterion).
The distributions of the averaged DNA methylation for all studied genes, expressed as the
percentage of 5-methylcytosine (%5mC), are described in Supplementary Table S1.
The distribution of ambient PM2.5 exposure in the week, 6 months and 1 year before the acute
event is reported in Supplementary Figure S1.
2.2. Association between PM2.5 Exposure and Clock Gene Methylation
We evaluated the association between PM2.5 exposure across different time periods (individual
days from −1 to −7, 6 month average, and 1 year average) and methylation level of clock genes.
Supplementary Table S2 reports all the association coefficients.
Considering the association between PM2.5 exposure at different time lags (individual days from
−1 to −7, 6 month average, and 1 year average) and methylation level of clock genes, we observed
that CLOCK, PER2, CRY1, and NPAS2 were associated with PM2.5 levels in the 4–5 days before the
event (Figure 1). In particular, CLOCK and PER2 were negatively associated with PM2.5 exposure in the
4 days before the stroke event, (P4days = 0.018 for CLOCK and P4days = 0.032 for PER2), while CRY1 and
NPAS2 were positively associated with the PM2.5 exposure in the 5 days before the stroke event (P5days
= 0.046 for CRY1 and P5days = 0.009 for NPAS2). CRY1 also showed long-term significant association
with the 6 month average of PM2.5 exposure before the event.
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2.4. Association between Clock Gene Methylation and NIH Stroke Scale (NIHSS) Score 
We further investigated the possible association between clock gene methylation and the NIHSS 
score evaluated at admission, and we observed that ARNTL methylation was negatively associated 
with NIHSS score (∆% = −2.2, 95% CI −4.13; −0.27, p-value= 0.026) (Table 3).  
 
  
Figure 1. Association between PM2.5 exposure and clock gene methylation. Linear mixed-effect
regression models were adjusted for age, sex, smoking habits, warm/cold months (months with heaters
switched on/off), run, position and plate. Panel (A–D) represent beta regression coefficients and 95% CI
for CLOCK, NPAS2, CRY1, and PER2 methylation, respectively.
2.3. Association between PM2.5 Exposure and NIH Stroke Scale (NIHSS) or Modified Rankin Scale Score for
Neurologic l Disability
PM2.5 exposure at different time points (individual days from −1 to −7, 6 month average, and
1 year average) was not associated with NIHSS score evaluated at admission, n r was it ssociated
with Modifi d R nkin Scale for Neurological Di ability score.
Association coefficients are reported in Supplementary Table S3.
2.4. Association between Clock Gene Methylation and NIH Stroke Scale (NIHSS) Score
We further investigated the possible association between clock gene methylation and the NIHSS
score evaluated at admission, and we observed that ARNTL methylation was negatively associated
with NIHSS score (∆% = −2.2, 95% CI −4.13; −0.27, p-value= 0.026) (Table 3).
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Table 3. Association between clock gene methylation and NIH stroke scale (NIHSS) score and Modified
Rankin Scale for Neurological Disability score.
Scale Clock Gene Methylation ∆% 95% CI p-Value
NIHSS score
ARNTL −2.22 −4.13 −0.27 0.0256
CLOCK −0.13 −2.21 1.99 0.9038
NPAS2 −0.88 −2.72 0.98 0.3510
CRY1 −2.98 −8.65 3.05 0.3251
CRY2 1.93 −9.38 14.66 0.7498
PER1 0.87 −2.00 3.83 0.5550
PER2 −0.03 −0.32 0.27 0.8622
PER3 −0.25 −0.59 0.09 0.1543
Modified Rankin score
ARNTL 0.35 −4.37 5.31 0.8857
CLOCK 1.77 −1.91 5.59 0.3493
NPAS2 −1.92 −4.50 0.73 0.1537
CRY1 8.39 1.92 15.28 0.0103
CRY2 7.51 −2.65 18.73 0.1527
PER1 −3.12 −6.01 −0.14 0.0406
PER2 −0.24 −0.50 0.02 0.0756
PER3 −0.25 −0.56 0.07 0.1253
Linear regression models were adjusted for age, sex, smoking habits, diabetes, hypertension, PM2.5 annual average,
warm/cold months, plate, and therapy (only for Rankin score). Scores were log (base e)-transformed to achieve
a normal distribution. ∆% is equal to (exp(β/10)–1) × 100 and represents the percentage increase in NIHSS or
Modified Rankin score for 0.15mC% increase in clock gene methylation. Clock genes with a p-Value ≤ 0.05 are
reported in bold.
However, when the interaction between clock gene methylation and long-term exposure to PM2.5
(1 year average) was considered, we observed a strong modifying effect of PM2.5 in modulating
the association between clock gene methylation and NIHSS score. The interaction test formally
performed to assess effect modification was statistically significant for CRY1 (p-value = 0.031) and
CRY2 (p-value = 0.036). Thus, the association between CRY1/CRY2 and the NIHSS score was modified
by long-term PM2.5 exposure. The strength of this association in terms of percentage increase in
NIHSS score observed for each 0.1% rise in CRY1/CRY2 methylation percentage at three fixed levels
of 1 year PM2.5 average (minimum: 22 µg/m3, mean: 26.7 µg/m3, maximum: 30 µg/m3) is reported
in Figure 2. At low concentrations of PM2.5 (22 µg/m3), an NIHSS score increase of 27.7% for each
0.1% increment in CRY1 methylation and an NIHSS score increase of 45.9% for each 0.1% increment
in CRY2 methylation (∆% = 27.7, 95%CI 4.7;55.6, p-value= 0.0156 and ∆% = 45.9, 95% CI 0.1;111,
p-value= 0.0441, respectively) was observed. For high levels of PM2.5 (30 µg/m3), we observed a
decrease of 19.5% in NIHSS score for each 0.1% increment in CRY1 methylation (∆% = −19.5, 95% CI
−29.2;−8.5, p-value = 0.0009), while the association between CRY2 methylation and NIHSS score was
not significant (∆% = −12.9, 95% CI −31.0;10.0, p-value = 0.2468). At mean concentrations of PM2.5
(26.7 µg/m3) the association was not significant for CRY1 or for CRY2 (∆% = −2.6, 95% CI −8.1;3.1,
p-value = 0.3604 and ∆% = 7.8, 95% CI −3.7;20.6 p-value= 0.1939, respectively).
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after the event (∆% = 8.4, 95% CI 1.9;15.3, p-value= 0.010), while PER1 was negatively associated with the
Rankin score (∆% = −3.1, 95% CI –6.0;−0.14, p-value= 0.041). As we applied an approach similar to the one
used for the NIHSS score, we observed a strong modifying effect of 1 year average PM2.5 in modulating
the association between clock gene methylation and Rankin score (Figure 3). In particular, the formal
interaction test was statistically significant for CRY1 (p-value = 0.007), CRY2 (p-value = 0.002), and NPAS2
(p-value = 0.021). At low levels of PM2.5 (22 µg/m3), we observed an increase of Rankin score for each 0.1
5mC% increment in CRY1, CRY2, and NPAS2 (∆% = 32.8, 95% CI 14.4;54.2, p-value =0.0002,∆% = 64.3, 95%
CI 25;115.9, p-value =0.0004 and ∆% = 11.1, 95% CI −0.2;23.7, p-value= 0.0546, respectively). In contrast, at
high levels of PM2.5 (30 µg/m3), CRY1, CRY2, and NPAS2 were associated with a decrease in the Rankin
score (∆% = −4.7, 95% CI −14.7;6.4, p-value= 0.3939, ∆% = −11.9, 95% CI −24.7;3.0, p-value= 0.0113 and
∆% = −9.0, 95% CI −15.1;−2.5, p-value= 0.0075, respectively).
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3. Discussion
According to a recent report from the Global Burden of Disease, the estimated global lifetime risk of
stroke in 2016 for those aged 25 years or older was 24.9%, an increase from the estimated 22.8% in 1990.
Notably, stroke remains the second leading cause of death worldwide, with 5.5 million (95% uncertainty
interval (UI) 5.3–5.7) deaths attributed to this cause in 2016 [22]. Moreover, the prevalence of stroke is
expected to increase.
Among the stroke risk factors, smoking, poor diet, and physical inactivity accounted for 66%,
while environmental risks (air pollution and lead exposure) accounted for about 28%.
Int. J. Mol. Sci. 2020, 21, 3090 9 of 14
Short-term exposure to PM has been associate with stroke incidence [20], as well as with increased
mortality in stroke patients [23].
An increasing amount of evidence shows that the disruption of circadian rhythms might contribute
to the development of stroke [24]. In particular, stroke has a 24 h rhythm related to incidence and
disease burden, as stroke onset increases in frequency upon awakening in humans between 6 AM and
12 PM [25]. These variations have been explained as being due to circadian variation in the autonomic
nervous system [26] or to relevant cardiovascular risk factors that are regulated by peripheral circadian
clocks, such as platelet aggregation [27].
In the present study, we showed that clock gene methylation was modified by short-term PM2.5
exposure. Moreover, DNA methylation of some of the clock genes we investigated (i.e., CRY1, PER1)
was associated with Rankin score. Finally, if the annual average of PM2.5 was low, the association
between CRY1/CRY2 methylation and the NIHSS score was significant and positive, whereas it became
negative and significant if PM2.5 exposure was high. A similar behavior was also observed for the
Rankin score as, if annual average of PM2.5 was low, the association with CRY1/CRY2/NPAS2 was
significant and positive, whereas it became negative and significant if PM2.5 exposure was high.
The investigation of clock gene methylation in response to environmental stimuli is still in its
infancy. To the best of our knowledge, the only available paper on this topic was published by our
research group, in a population of mother–infant pairs from the ENVIRonmental influence ON Italy
AGEing (ENVIRONAGE) birth cohort. The key finding of this study was that PM2.5 influences the
methylation pattern of genes in the circadian pathway. In particular, we observed an increased
methylation of NPAS2, CRY1, PER2, and PER3 with an increase in 3rd trimester PM2.5 exposure [21].
Although the experimental conditions of this previous investigation were very different from those of
the present paper, the increase of methylation in CRY1 and NPAS2 was coherent in the two studies,
while stroke patients showed a decrease in PER2 methylation, which was not present in healthy
placental tissues.
The modification effect of long-term exposure to PM on clock gene methylation is particularly
intriguing, as we can speculate that it might be a proxy of the inflammatory status of the patients.
In vitro and in vivo animal studies suggest that C-reactive protein (CRP) levels increase in response to
PM exposure, but there is no consistency in epidemiological studies. In the present study, CRP levels
were within the normal range. A possible explanation could be the consumption of anti-inflammatory
drugs, especially in subjects affected by chronic conditions. However, long-term exposure to PM has
been consistently associated with increased level of low-grade inflammation, supporting the biological
link between PM exposure and deteriorating cardiovascular health. Moreover, chronic exposure to PM
has been linked to increased fibrinogen, which plays a key role in the clotting cascade. Fibrinogen has
procoagulant and pro-inflammatory properties, and promotes atherothrombosis [28].
A second hypothesis is that, as clock genes are modulated by short-term PM2.5 exposure, long-term
exposure might cause a sort of “adaptation”, which makes certain patients less responsive to short-term
PM2.5 exposure and therefore less able to hypermethylate clock genes.
From the clinical point of view, we could speculate that this biomarker could help the general
approach to patients with acute stroke. For instance, it could be helpful for a better stratification of
stroke patients at higher risk in the acute setting. In addition, it could also be possible to use this marker
to identify specific patterns of response to acute treatments such as thrombolysis. Finally, a possible
prognostic role could help to identify the best treatment strategy for these patients.
The present study must be interpreted taking into account both its strength and its limitations.
First, although the number of recruited patients was limited, the inclusion criteria of this study were
very strict, allowing us to consider a very homogenous group of patients; all were recruited in the
same hospital, within 4.5 h from the onset of disease, and before any clinical intervention. Moreover,
we collected very detailed information about possible confounding factors and we were able to consider
them in the statistical analyses. Second, in this study, we investigated the effects of PM2.5 as the principal
exposure. However, air pollution involves exposure to a complex mixture of gaseous and particulate
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environmental pollutants, such as fine and ultrafine particles, nitrogen dioxide, ozone, and sulfur
dioxide. Therefore, we cannot exclude effects from other pollutants as well as interactions between
different pollutants.
Third, all the methylation analyses in this study were conducted on buffy coat. Although PM
enters the body through the airway, which is the first body district impacted by this type of exposure,
several studies have demonstrated that PM exposure affects DNA methylation in blood cells, and
the majority of the study in the field have been conducted as bulk analyses by evaluating buffy coat
samples [29–31].
The interplay between long-term exposure, CRY methylation, and NIHSS score raises new
questions on the possible role of chronic exposure in modulating DNA methylation. This effect might
thus be associated with patient prognosis following stroke. Future studies investigating gene expression
and focusing on changes in DNA methylation occurring over time are required, together with those
aimed at unveiling the role of clock gene methylation in regulating the response to and recovery after a
stroke event.
Our findings are promising, although based on a small sample mainly due to the difficulty in
recruiting this type of subject. Thus, further studies on larger populations, such as multicenter studies,
are warranted in order to confirm the evidence described here.
4. Materials and Methods
4.1. Study Population
From September 2016 to March 2018, we enrolled 55 patients admitted to the Emergency
Department (ED) of Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico (Milan, Italy) with
a diagnosis of acute ischemic stroke and presenting within 4.5 h from the onset of neurological clinical
symptoms. Inclusion criteria were: age > 18, an ischemic origin of stroke, onset of symptoms in the
previous 4.5 h, symptoms present at least for 30 min without any clinically relevant improvement, and
absence of any significant mass effect resulting in a shift of midline. Exclusion criteria were: primary
intracerebral hemorrhage, absence of stable spontaneous sinus rhythm on the ECG at presentation,
clinically relevant pre-existing neurological deficit, generalized seizures at the onset of stroke symptoms,
severe organ failure, cerebral or extracerebral cancer disease with reduced life expectancy, mechanical
ventilation, or consent refusal.
For each patient, we collected demographics, anthropometrics, clinical, ongoing drug therapy,
and standard laboratory evaluations performed in the Emergency Department.
All subjects gave their informed consent for inclusion before they participated in the study.
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was
approved by the Ethics Committee “Comitato Etico—Milano Area 2” of the Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy (approval number 1443/2016).
Patients underwent diagnostic and therapeutic procedures according to International and Internal
Guidelines for the treatment of acute ischemic stroke. Stroke severity was evaluated using the National
Institutes of Health Stroke Scale (NIHSS), a scale based on the evaluation of 11 neurological items with
an overall score which ranges from 0 to 42, with higher scores indicating more severe neurological
impairment [32]. The Modified Rankin Scale (mRS) measures the degree of dependence in daily
activities of patients with stroke [22]. The scale ranges from 0 (patient without symptoms), to 6 (patient
death); a value of 5 means a patient with severe disability and requiring constant care. We considered
mRS at 3 months as a medium-term outcome [33].
4.2. Exposure Assessment
PM2.5 concentrations were assigned to each participant’s residential address from September 2016
to March 2018. The PM2.5 concentrations were recorded by the Regional Environmental Protection
Agency (ARPA Lombardia) through monitoring stations located throughout Lombardy and available
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online as daily means. To assign a PM2.5 exposure level to each subject, the addresses of the monitoring
stations and the study subjects were geocoded and the PM2.5 measured by the nearest monitor to
residential address was assigned. We chose to investigate short-term PM2.5 exposure (we used the daily
means of PM2.5 concentrations measured 1 day before the date of recruitment and back to 7 days before
enrollment) as well as long-term PM2.5 exposure (6 month and 1 year averages). In cases of incomplete
series, missing values were attributed using an algorithm that integrated the annual average of the
incomplete series and the PM2.5 concentrations of the nearest and more correlated monitors [34].
4.3. Sample Collection, DNA Extraction, and Bisulfite Treatment
Seven millilitres of whole blood were collected into EDTA tubes from each participant by venous
phlebotomy. Blood was centrifuged at 1200 g for 15 min. The buffy coat fraction was transferred to a
cryovial and immediately frozen at −80 ◦C until use. DNA was extracted using a Wizard Genomic
DNA purification kit (Promega, Madison, WI, USA) according to the manufacturer’s instructions.
Next, 500 ng of genomic DNA was treated with the EZ DNA Methylation-Gold™ Kit (Zymo Research,
Orange, CA, USA) in accordance with the manufacturer’s protocol. Bisulfite-treated DNA was eluted
in 30 µL of M-Elution Buffer and kept at −80 ◦C until use.
4.4. DNA Methylation
Analysis of DNA methylation was performed via previously published methods [21,35,36] with
minor modifications. Briefly, a 50 µL PCR reaction was carried out with 25 µL of Hot Start GoTaq Green
Master mix (Promega), 1 pmol of forward primer, 1 pmol of biotinylated reverse primer, and 25 ng
of bisulfite-treated genomic DNA. Biotin-labeled primers were used to purify the final PCR product
with sepharose beads. The PCR product was bound to a Streptavidin Sepharose HP (Amersham
Biosciences, Uppsala, Sweden). Sepharose beads containing the immobilized PCR product were
purified, washed, denatured with 0.2 M NaOH, and washed again with the Pyrosequencing Vacuum
Prep Tool (Pyrosequencing, Inc., Westborough, MA, USA) according to the manufacturer’s instructions.
Pyrosequencing primer (0.3 µM) was annealed to the purified single-stranded PCR product, and
pyrosequencing was performed with the PyroMark MD System (Pyrosequencing, Inc. Westborough,
MA, USA). CpG sites were interrogated within the promoter regions of the following genes: ARNTL,
CLOCK, NPAS2, CRY1, CRY2, PER1, PER2, PER3.
PCR cycling conditions and primer sequences are reported in Supplementary Table S4.
The methylation level at CpG positions within each gene’s promoter region was expressed as the
percentage of cytosines that were methylated, determined as the number of methylated cytosines divided
by the sum of methylated and unmethylated cytosines, multiplied by 100% (% 5-methyl-cytosine).
Every sample was tested twice for each marker to confirm reproducibility and to increase the precision
of the findings.
4.5. Statistical Analysis
The data were summarized with standard descriptive statistics. Categorical variables were
presented as absolute numbers and frequencies. Continuous variables were expressed as the
mean ± standard deviation (SD) or as the median (first quartile–third quartile), as appropriate.
To estimate the effect of PM2.5 exposure on clock gene methylation, we fitted linear mixed-effect
models adjusted for age, sex, smoking habits, and warm/cold months. DNA methylation measurements
for each subject were run in duplicate. The pyrosequencing-based DNA methylation analysis tested a
variable number of CpG positions according to CpG density in the promoter assay. Linear mixed-effect
models were used to account for each CpG dinucleotide position (as a random effect) measured in the
two runs and the potential confounding effect of the plate. An unstructured covariance structure was
used to model within-subject errors. The Kenward–Roger approximation was used to estimate the
degrees of freedom in the denominator.
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We further evaluated the associations of different time of PM2.5 exposure (short- and long-term
exposure) with NIHSS and Modified Rankin scores. We performed linear regression models adjusted
for age, sex, smoking habits, diabetes, hypertension, warm/cold months, and therapy (for Modified
Rankin score). Dependent variables were log-transformed (base e) to achieve normality of models’
residuals. Effects were thus expressed as ∆% with a 95% confidence interval (CI), which corresponded
to (exp(β)–1) × 100 and represented the percentage increase in NIHSS or Modified Rankin score for
1µg/m3 increase in PM2.5. In considering the effect of clock gene methylation on NIHSS score and
Modified Rankin score, we examined the potential effect modification of long-term PM exposure (i.e.,
PM2.5 annual average). Effects were thus expressed as ∆% with a 95% confidence interval (CI), which
corresponded to (exp(β/10)–1) × 100 and represented the percentage increase in NIHSS or Modified
Rankin score for a 0.1% increase in clock gene methylation.
Normality and linearity assumption were verified by graphical inspection. A p-value of 0.05
was considered statistically significant. All analyses were performed in SAS 9.4 (SAS Institute Inc.,
Cary, NC, USA).
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/9/3090/
s1. Table S1. Mean levels of gene methylation (%5mC) of the studied population (n = 55). Table S2. Association
between PM2.5 exposure and clock gene methylation. Table S3. Association between PM2.5 exposure and
NIH-STROKE SCALE (NIHSS) and Modified Rankin Scale for Neurologic Disability. Figure S1. Box plot showing
the distribution of PM2.5 concentrations for the exposure intervals defined.
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